Here, we identified a paracrine OPN/integrin αvβ3/FOXM1 cascade that modulates the EMT and CSC‐like properties of pancreatic cancer, providing a promising therapeutic target for patients with pancreatic cancer. Here, SPP1 is linked to pancreatic neoplasm.